In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-13 of 13 for your search:
Cancer Type/Condition:  Prostate cancer
Trial Type:  Prevention
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: ROI10-352, R01CA138627, NCT01296672

2.

Phase: Phase III
Type: Prevention
Status: Active
Age: 40 to 80
Sponsor: Other
Protocol IDs: BE-2-27, NCT00780754

3.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00451, UWI09-14-01, CDR0000698228, CO-10805, N01CN35153, P30CA014520, NCT01325311

4.

Phase: Phase II
Type: Prevention
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: AMC-PC2012002, NCT01759836

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: Over 19
Sponsor: Other
Protocol IDs: 264-2013, NCT02037464

6.

Phase: Phase II
Type: Prevention
Status: Approved-not yet active
Age: 50 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: MCS-8-II-TWN, NCT02042807

7.

Phase: Phase II
Type: Prevention
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 13-6823, NCT02043236

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00695, CO11378, UWI2013-00-01, P30CA014520, N01CN00033, N01CN35153, NCT02095145

9.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 80
Sponsor: NCI
Protocol IDs: NCI-2012-00085, CDR0000717828, I 182210, NWU09-4-03, N01CN35157, P30CA060553, NU-NWU09-4-03, NCT01497431

10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: 12-000886, NCI-2013-01153, P30CA016042, R03CA171583, NCT01912820

11.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 20 to 60
Sponsor: Other
Protocol IDs: 07/09/VA18, NCT00562341

12.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: Portland VA-09-0607, 2096, 6232, 2PO1CA090890-06A2, NCT01265953

13.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: ZEM 21 AII, NCT01538316
New Search